Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions (SS-SBVPT)
Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions Multi-center,Randomized, Double-blind, Placebo-controlled Clinical Study
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
Listed as NCT01750775, this PHASE4 trial focuses on Premature Ventricular Contraction and remains ongoing. Sponsored by Chinese Academy of Medical Sciences, Fuwai Hospital, it has been updated 6 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
Status: Enrolling By Invitation → Unknown Status
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation PHASE4
First recorded
Aug 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Third Military Medical University
- kejiang Cao
For direct contact, visit the study record on ClinicalTrials.gov .